In the study cohort, 2,310 patients died during a median follow-up of 6.3 years, and prostate cancer accounted for 454 (19.7% ...
In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total ...
In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...
Representative Julie Johnson (D-Texas) recently sold shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 ...
Fintel reports that on March 14, 2025, Citizens Capital Markets upgraded their outlook for Allogene Therapeutics ...
Taiwan Semiconductor Manufacturing, Salesforce, Oracle, Exxon Mobil, ServiceNow, D-Wave Quantum, and Pfizer are the seven Manufacturing stocks to watch today, according to MarketBeat’s stock screener ...
Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...
(Reuters) - Kohl’s (NYSE: KSS) on Friday changed the title of its chief DEI officer and broadened its supplier diversity ...
This latest study shows the vaccine does not increase the risk of having a baby born with major birth defects.
Treatment-experienced patients with moderate to severe atopic dermatitis attained higher efficacy rates on rocatinlimab ...
Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...